May 19, 2012 Using Translatability Assessment to Refine a Patient-Reported Outcome (PRO) Measure During The Development Process
May 16, 2012 Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
May 15, 2012 Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
May 15, 2012 Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
May 15, 2012 Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
May 15, 2012 Drug-Resistant Tuberculosis–Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
May 2, 2012 Renewed Focus on Tuberculosis Holds Promise for New Treatments FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microproc
